Magentabletten

Magnesium Trisilicate, the active ingredient in Magentabletten, is an antacid presented as an oral tablet for oral use. It neutralizes excess stomach acid and provides gastrointestinal protection, commonly employed to relieve symptoms of heartburn, acid indigestion and to protect the gastric mucosa in patients requiring acid reduction and to aid in managing conditions where acid suppression is desired.

GNH USA supplies Magentabletten as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Magnesium Trisilicate is an antacid that acts by neutralizing gastric acidity and is used in several gastrointestinal conditions. - Heartburn: quickly neutralizes stomach acid to relieve burning sensation in the chest and throat. - Acid indigestion: reduces excess acidity after meals, alleviating discomfort and bloating. - Gastric ulcer prophylaxis: provides a protective barrier on the gastric lining for patients at risk of ulcer formation, such as those taking NSAIDs. - Functional dyspepsia: eases upper abdominal discomfort, fullness, and early satiety associated with dyspeptic symptoms. - Mild gastro‑esophageal reflux: helps control occasional heartburn and regurgitation by raising gastric pH.

Magnesium trisilicate may be associated with several adverse reactions, most of which are mild and transient.

Common Side Effects: - Constipation: occasional hard stools or difficulty passing bowel movements. - Diarrhea: loose, watery stools that may occur with higher doses. - Nausea: mild stomach upset or feeling of queasiness after ingestion.

Serious or Rare Side Effects: - Hypermagnesemia: elevated magnesium levels causing muscle weakness, low blood pressure, or cardiac rhythm changes, primarily in patients with renal failure. - Allergic reaction: rash, itching, swelling, or rare anaphylaxis requiring immediate medical attention. - Metabolic alkalosis: excessive rise in blood pH leading to confusion, tremors, or respiratory disturbances, usually with prolonged overuse.

When using magnesium trisilicate, certain precautions should be observed to ensure safe and effective therapy. - Renal function: assess kidney function before initiating therapy, as impaired clearance can increase magnesium levels. - Concomitant medications: review use of other antacids or magnesium‑containing products to avoid excess intake. - Pregnancy and lactation: use only if clearly needed and prescribed, because safety data are limited. - Chronic use: limit duration to the shortest period required to control symptoms, avoiding long‑term overuse. - Elderly patients: monitor for constipation or electrolyte disturbances, as they may be more susceptible. - Store at ambient temperature: keep tablets in the original container, protect from moisture and direct sunlight.

Magnesium trisilicate can affect the absorption or action of several other medicines; awareness of key interactions helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Tetracycline antibiotics: magnesium binds to tetracyclines, markedly reducing their oral absorption. - Fluoroquinolone antibiotics: co‑administration can lower fluoroquinolone bioavailability through chelation. - Iron supplements: simultaneous intake decreases iron absorption, potentially compromising anemia treatment.

Moderate Interactions (Monitor Closely): - Warfarin: magnesium may potentiate anticoagulant effect; monitor INR when starting or stopping. - Levothyroxine: antacid may reduce levothyroxine absorption; separate dosing by at least 4 hours. - Digoxin: magnesium levels can influence digoxin toxicity; monitor serum digoxin in patients with renal impairment.